#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mycobacterium abscessus infection Thrombotic thrombocytopenic purpura Astrocytoma malignant Erythema multiforme Osteosarcoma recurrent Acute hepatic failure Short-bowel syndrome Albright's disease Demyelination Primary hyperoxaluria Medulloblastoma Chronic cutaneous lupus erythematosus Central nervous system neoplasm Chronic granulomatous disease Paraneoplastic neurological syndrome More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy Mucopolysaccharidosis I – Basic Information Immunodeficiency congenital Anaplastic thyroid cancer – Diagnostics Hereditary ataxia – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Basic Information Phenylketonuria – Life with Disease Epidermolysis bullosa Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Ewing’s sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydroxocobalamin Oxitriptan Rintatolimod Monalizumab Secale Cereale Masofaniten Selumetinib Sitagliptin Vincristine Sulfate Efinopegdutide OMECAMTIV MECARBIL STREPTOCOCCUS PYOGENES Evx-01 Valproate Semisodium Lidocaine Hydrochloride Rosuvastatin Zinc Burfiralimab Leucine RNMB2 Bay 3283142 More therapies…

    Learn about Your Condition

    Dementia with Lewy bodies Narcolepsy Neurotrophic keratopathy Migraine Weaning failure Thermal burn Monogenic diabetes Arterial tortuosity syndrome Infantile apnoea Embolic stroke Chondrosarcoma metastatic Carpal tunnel syndrome Arginase deficiency Breast proliferative changes Univentricular heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Phase 2 Study of RADAMTS13 in Adults with Acute Ischemic Stroke

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Belgium France Germany Greece

  • Phase II Study of Cemiplimab to Spare Surgery in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Italy

  • Safety and Tolerability of Lutetium‑177 Vipivotide Tetraxetan Combined with Gozetotide in Women with Metastatic Triple‑Negative Breast Cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Germany

  • Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • Pegcetacoplan
    France Germany Italy Poland Portugal Slovakia +1

  • Model‑informed precision dosing of linezolid in ICU patients with bacterial pneumonia, skin or soft‑tissue infection: a randomized clinical trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Linezolid
    Germany

  • Sodium Oxybate for Nocturnal Cluster Headache Attacks in Adults with Chronic Cluster Headache: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Sodium Oxybate
    The Netherlands
Previous Page
1 … 678 679 680 681 682 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!